Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer

ConclusionsThis study demonstrated the valuable roles of circulating exosomal miR-1246 and miR-155 in distinguishing trastuzumab resistant from sensitive patients.

Source: Cancer Chemotherapy and Pharmacology - October 17, 2020 Category: Cancer & Oncology Source Type: research